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Abstract
Chronic liver disease (CLD) presents as jaundice and abdominal distention. It has significant morbidity and mortality. CLD is often 
associated with cirrhosis of the liver and causes of CLD vary from infection to metabolic diseases. Here we present a case of a 
7-year-old female who presented with abdominal distention and shortness of breath. Her liver function tests were not normal. An 
enlarged liver was found on ultrasound and computed tomography scan showed moderate ascites with heterogeneous nodular 
enhancement on the liver surface. Workup for Wilson disease, viral infections, and autoimmune causes was found to be negative. 
There was no evidence of metabolic diseases. Biopsy of the liver showed evidence of cirrhosis. No evidence of esophageal varices 
was found. Supportive management for CLD was started. The case highlights the importance of detailed workup for identification of 
the cause which can be difficult in a resource-limited setting.
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INTRODUCTION
In the pediatric population injury to the liver typically 
manifests itself as jaundice, deranged liver function test, 
and hepatomegaly. It could be due to various etiologies; 
infective, metabolic or neoplastic. Biliary atresia and 
neonatal hepatitis can also occur [1]. Disorders of liver 
particularly chronic liver diseases (CLDs) represent 
a major public health concern in low to high-income 
countries [2]. Chronic liver failure is most often 
associated with cirrhosis, a condition manifested by a 
diffuse transformation of the entire liver into regenerative 
parenchymal nodules surrounded by fibrous bands and 
variable degrees of vascular shunting. In association 
with modifiable and non-modifiable risk factors, the 
prevalence of clinically significant liver fibrosis differs 
between 0.7% and 25.7% among the general population 
[3]. Although more prevalent among adults, chronic liver 
disease is a common cause of morbidity and mortality in 
children. The etiological profile of chronic liver disease 
varies with geographical location. Hepatitis virus is a 
leading cause of chronic liver disease in South East Asia, 
the Middle East, and some other Asian countries [4]. The 
major presenting complaints of chronic liver disease 
are jaundice and abdominal distension. However, in 
the pediatric population, poor weight gain is often the 
primary sign of cirrhosis. Due to late presentation and 
concomitant complications at the time of diagnosis, it 
is typically associated with poor prognosis. In infants, 
cirrhosis is generally caused by metabolic and genetic 
diseases and biliary atresia while in older children, it can 
be a consequence of chronic viral hepatitis, autoimmune 
hepatitis, alpha-1 antitrypsin deficiency, Wilson disease 
or primary sclerosing cholangitis. Other less common 
causes include drug toxicity, Allagile syndrome, Wolman 
disease, hemochromatosis, and other inherited disorders 
[5]. The analysis of CLD cases in the pediatric population 
reported from tertiary care hospitals in Rawalpindi 
and Islamabad, Pakistan demonstrated that 31.6% of 
the patients had hepatitis C and 5% had hepatitis B. 
Glycogen storage diseases were seen in 8.3% cases 
while biliary atresia and Wilson disease constituted about 
8% each. Autoimmune hepatitis, drug-induced hepatitis, 
TORCH infections, and hepatoma were seen as less 
common cases accounting for about 1.7% each [6]. The 
complications of pediatric cirrhosis are identical to those 
observed in adult patients. Gastrointestinal bleeding 
due to esophageal varices or congestive gastropathy, 
ascites and spontaneous bacterial peritonitis are major 
complications of chronic liver disease. The present 
case emphasizes the unusual presentation of pediatric 
chronic liver disease and its diagnostic evaluation. 
Further, we have also highlighted supportive treatment 
protocol followed leading to better outcomes.
CASE PRESENTATION
An Afghan origin seven-year-old girl, unvaccinated, 
without any premorbidity presented to the emergency 
department of Abbasi Shaheed Hospital with a history 
of gradual distension of abdomen for two months and 
difficulty breathing for a day. 
The child was in her usual state of health two years back 
when she developed pain in the right hypochondrium. 
The pain was mild, dull, and non-radiating. It was not 
associated with vomiting, food intake, movement, fever 
or cough. The pain was relieved by taking analgesics.
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An abdominal exam by a local doctor revealed that 
the child had an enlarged liver and further workup was 
advised. Her abdominal distension gradually increased 
in the last two months to such an extent that she had 
difficulty breathing and passing urine. There was no 
history of jaundice, bleeding, itching, melena, abnormal 
movements, altered behavior or headache. No history 
of blood transfusion and medication was present. 
Birth history was insignificant. There was no history 
of prolonged jaundice in infancy. Family history of 
tuberculosis or bleeding disorder was insignificant.
Physical examination showed that the child was pale with 
gross abdominal distension. Swelling of lower limbs up to 
the level of the sacrum was noted. She was tachypneic 
and tachycardic but afebrile. Her anthropometric 
measurements were below the 10th centile. No evidence 
of hepatic encephalopathy was present. Other systemic 
examinations were normal.
A complete blood picture showed leukocytosis. Kidney 
functions were normal. Liver function tests were 
deranged (Table 1).
Table. 1: Values of different parameters.
Parameters Values
Total bilirubin 0.6 mg/dl





Prothrombin Time 20 seconds
INR 1.14
AST-aspartate aminotransferase, ALT-alanine aminotransferase, ALP- 
alkaline phosphate, INR- International Normalized Ratio.
Ultrasound abdomen with Doppler studies showed 
enlarged liver span (12.5 cm) with coarse echotexture and 
splenomegaly (9.3 cm) with gross ascites but no dilated 
vessels/portal vein. Computed tomography (CT) scan 
abdomen showed moderate ascites, heterogeneous 
nodular enhancement of liver but there was no evidence 
of duct dilation. Echocardiography was normal. The 
differential diagnosis of viral hepatitis, autoimmune 
hepatitis, Wilson disease, hemochromatosis, 
tyrosinemia, metabolic disorders were considered. The 
child was worked up for various etiologies of chronic 
liver disease. Viral markers (A, B, C, D and E) were 
normal and workup for Wilson’s disease was negative. 
Markers for autoimmune hepatitis (anti-LKM 1 antibody 
and anti-smooth muscle antibody), tyrosinemia (alpha-
fetoprotein) and inborn errors of metabolism (arterial 
blood gases, serum lactate, serum ammonia, blood 
sugar) were within normal limits. However, due to 
financial constraints, the workup for glycogen storage 
diseases and lysosomal storage disorders was not 
done. Stool for occult blood was positive. All cultures 
(blood, urine, and ascitic fluid) were negative.
The child was started on supportive management for 
chronic liver disease and was managed in line with a 
deranged coagulation profile and received fresh frozen 
plasma (FFP) and packed cells during the admission. 
Further treatment included fat-soluble vitamins in 
recommended doses according to age, intravenous 
antibiotic, lactulose, and ascitic paracentesis. Her 
endoscopy was done on the 10th day of admission 
which showed no esophageal varices but congestive 
gastropathy was seen. 
Liver biopsy was done which revealed a single linear 
core of liver parenchyma showing mild periportal 
inflammation as well as septal fibrosis with architectural 
distortion and nodule formation. No significant increase 
in plasma cells was seen in inflammatory infiltrate. 
Special stain for iron (Perl) was negative. Hence, 
according to Batt’s and Ludwig’s grading and staging 
system of chronic hepatitis, it was mildly active (grade 
II) with septal fibrosis and nodule formation (cirrhosis, 
stage IV fibrosis).
The child clinically improved on the 20th day of admission. 
Her parents were counseled regarding liver transplant 
and frequent follow-up.
DISCUSSION
There is a vast array of clinical findings associated 
with hepatic cirrhosis in the pediatric population. The 
typical manifestations of hepatic cirrhosis are jaundice, 
abdominal distension, hepatomegaly, splenomegaly, 
edema, and anemia [7]. However, when associated 
with complications, the patient can present with ascites, 
coagulopathy from decreased hepatic synthetic function, 
variceal bleeding and congestive gastropathy due to 
portal hypertension, spontaneous bacterial peritonitis, 
and hepatic encephalopathy which are indicators of 
decompensated disease [8]. In our case, the patient 
presented with anemia, moderate abdominal pain and 
progressive distension causing difficulty in breathing and 
urination and edema of lower limbs. This is an atypical 
presentation as it is not associated with jaundice, the 
major presenting complaint of liver diseases. Further 
even manifested with moderate hepatosplenomegaly 
and leukocytosis, no association with fever, cough, rash, 
melena, dermatitis or altered neurological activity was 
present. However, the loss of caloric intake was noticed. 
Hepatic disorders are usually marked by deranged liver 
function tests, coagulation profiles and blood picture 
[9]. Identical to typical cases of chronic liver disease, 
the diagnostic laboratory findings of this patient were 
found to be altered i.e. abnormal bilirubin, total protein, 
albumin, aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), alkaline phosphate (ALP). 
Albeit different radiologic modalities may demonstrate 
the classic signs of cirrhosis, no test is considered 
to be standard [10]. Ascites, hepatosplenomegaly 
and hepatic or portal vein thrombosis can be easily 
detected by various radiologic studies. The degree 
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of hepatic fibrosis depicted by texture and increased 
echogenicity, splenic enlargement and degree of ascites 
are some of the findings that can be detected non-
invasively through abdominal ultrasonography [11-13]. 
The ultrasonographic evaluation of this patient showed 
hepatomegaly with a coarse texture, splenomegaly, and 
ascites. However, there was no dilation of the portal vein 
or other hepatic vessels observed on Doppler ultrasound 
which seems to be inconsistent with US findings of 
portal hypertension [11, 14]. Similarly, Computerized 
tomography scanning can help in categorizing chronic 
liver disease through differences in the degree of 
ascites, morphological differences in nodular fibrosis 
and associated extrahepatic manifestations [15]. The 
underlying pathophysiology of ascites is increased 
sinusoidal pressure due to hepatic fibrosis leading to 
the accumulation of excess fluid in the peritoneal cavity 
[16]. A moderate degree of ascites with heterogeneous 
nodular enlargement of the liver was noticed in the CT 
abdomen of this patient. Nevertheless, liver biopsy is 
considered as a gold standard in the evaluation of liver 
disease but is now needed less for diagnosis than for 
grading and staging of disease.
A number of studies demonstrate the variations in the 
etiological profile of hepatic cirrhosis in the pediatric 
population. Viral hepatitis, biliary diseases, autoimmune 
hepatitis, metabolic or genetic disorders like glycogen 
storage disorders, Wilson disease, hemochromatosis, 
cryptogenic and tyrosinemia are some of the prevalent 
causes of chronic liver disease in the pediatric population 
in different geographical locations [9, 17, 18].
In Pakistan, viral infections especially hepatitis B and C 
were observed to be the prime cause of deteriorating liver 
functions in the pediatric population [6, 19]. Surprisingly, 
despite the mother being diagnosed positive for hepatitis 
B, there were no diagnostic markers of hepatitis or any 
other viral infection in this patient. Similarly, the liver 
biopsy did not show the ground-glass appearance of 
hepatocytes and lymphoid follicles or fatty changes 
in scattered hepatocytes, the diagnostic hallmarks of 
hepatitis B and C respectively. Hence HBV and HCV as 
a cause of cirrhosis in this patient were excluded. 
Autoimmune hepatitis, a chronic and progressive form 
of liver disorder in which the body’s immune system 
attacks its own hepatocytes can also lead to scarring and 
consequently to liver failure. The presence of diagnostic 
autoantibodies especially anti-LKM1 is considered as 
a main serologic marker of autoimmune hepatitis type 
2 [20]. Although more prevalent in female teenagers 
and children the serological test of this patient did not 
show any presence of autoantibodies or increased 
immunoglobulin G. Further there were no signs of 
interface hepatitis on histological examination or family 
history of recurrent infections so autoimmune hepatitis 
was excluded.
Clinical signs and symptoms suggested that in our patient 
cirrhosis might have developed due to tyrosinemia, a 
genetic disorder characterized by disruptions in the 
breakdown of tyrosine. Type 1 tyrosinemia is usually 
seen in infants with failure to thrive, enlarged liver 
and spleen, jaundice, distended abdomen, increased 
tendency to bleed particularly nose bleeds and swelling 
of legs. While type 2 tyrosinemia is often presented 
in early childhood with painful red eyes, intellectual 
disabilities and skin manifestations. However, in chronic 
or complicated cases, tyrosinemia is often associated 
with hepatic cirrhosis [21]. In this case, the tyrosine and 
alpha-fetoprotein levels were not found to be elevated and 
there were no extrahepatic manifestations suggesting 
that the patient was not suffering from tyrosinemia.
In the differentials of this case, inborn errors of 
metabolism possess importance and clinical features 
suggest that patients might have glycogen storage 
disorders (GSDs) or lysosomal storage diseases (LSDs) 
[22, 23]. Although arterial blood gases, serum lactate, 
ammonia, and blood sugar were in their normal limits, 
we could not evaluate the characteristic enzyme levels 
specific for GSDs and LSDs due to financial constraints. 
Similarly, the liver biopsy did not show glycogen 
deposition or fat vacuoles and pathognomic abnormal 
cell accumulation. Furthermore, there were no bruising, 
neurological complications, involuntary muscle spasms, 
hypotonia or feeding problems in this child despite 
hepatosplenomegaly and anthropometric measurements 
below 10th centile which may exclude some common 
inborn errors of metabolism like Gauchers disease and 
GSD type Ia, Ib and III.
Biliary diseases either congenital or autoimmune are 
usually marked by jaundice, dark urine, gray or white 
stools, slow weight gain, abdominal pain, nausea, 
vomiting, itching, and fever. As the child has not 
developed any of these symptoms despite abdominal 
pain, we suggested that our patient was not suffering 
from any biliary disease. Similarly, laboratory workup and 
abdominal ultrasonography did not show autoimmune 
markers of primary sclerosing cholangitis and specific 
signs of biliary atresia or gallbladder abnormalities 
related to Allagile syndrome or choledochal cysts 
respectively [20, 24].
Among rare causes of hepatic cirrhosis, Wilson disease, 
hemochromatosis and alpha 1 antitrypsin deficiency 
have been associated with altered liver metabolism 
progressing gradually to liver failure in children. Wilson 
disease is an autosomal recessive disorder with impaired 
copper excretion in bile and a failure to incorporate 
copper in ceruloplasmin due to mutations in the ATP7B 
gene. This leads to the accumulation of toxic levels of 
copper in different organs of the body principally liver, 
brain, and eye. In this case, the child neither developed 
neurological or psychiatric signs and characteristic eye 
lesions of Wilson disease nor the clinical investigations 
and biopsy of liver demonstrated apparent signs of Wilson 
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disease i.e. lobular inflammation, ballooning, rosetting 
and Mallory hyaline [25]. Primary hemochromatosis is 
an inherited disorder with excessive iron absorption and 
deposition in parenchymal organs of the body. As Perl 
stain for iron was negative, hemochromatosis was also 
excluded [26]. Similarly, as there was no previous history 
of blood disorder requiring transfusions, it was suggested 
that our patient was not suffering from secondary 
hemochromatosis. Alpha 1 antitrypsin deficiency is 
also an important cause of cirrhosis in the pediatric 
population presenting as abdominal distension, ascites 
and gastrointestinal bleeding from esophageal varices 
and congestive gastropathy. Some of these children 
have a prior history of neonatal jaundice and transient 
elevation of aminotransferases in early childhood [27]. 
For diagnosis of alpha 1 antitrypsin deficiency (AATD), 
serum alpha 1 antitrypsin should be low and in this case, 
it was found to be negative.
Xenobiotic-induced liver damage poses a major concern 
for health care as it is associated with significant 
morbidity and mortality. Xenobiotics include a variety 
of agents, e.g. pesticides, aflatoxin (mycotoxin), and 
compounds like N-nitrosodimethylamine, hydrazine, 
and carbon disulfide. They can be generated through 
food processing. Metabolism of xenobiotics in the 
liver produces free radicals, electrophiles and highly 
reactive and unstable chemical species. These unstable 
molecules damage DNA enzymes, and organelles in 
hepatocyte. They alter the structure and function of the 
liver and can cause acute liver failure, liver cirrhosis, 
and even carcinoma of the liver. Xenobiotic induced liver 
damage manifests in a variety of ways and can be a 
diagnostic challenge for the physicians [28, 29]. In our 
case, the patient had no history of exposure to possibly 
harmful chemicals but the probability of xenobiotic 
induced liver damage cannot be ruled out.
As the underlying cause of cirrhosis remains unclear after 
extensive clinical, serologic and pathologic evaluation, 
this patient is labeled as a case of cryptogenic cirrhosis. 
Patients with indeterminate acute liver failure have higher 
rates of death and liver transplantation as compared 
to those with known causes. The research workshop 
sponsored by the National Institute of Diabetes and 
Digestive and Kidney diseases highlighted that the 
emerging treatment practices for indeterminate pediatric 
liver failure are not evidence-based. Specifically, the role 
of suppressing the immune response in pediatric patients 
with indeterminate liver failure through steroid therapy 
has not been tested adequately [30]. Since Pakistan 
is a third world country with an underdeveloped health 
care system and limited resources, the majority of rare 
cases remain undiagnosed and inadequately treated 
leading to an inclination of people towards spiritual and 
non-medicinal treatments. The improvement of this 
child with supportive management for unexplained CLD 
highlights the necessary consideration of evaluation and 
treatment protocol followed in cases of pediatric end-
stage liver disease despite knowing the definite etiology 
[31]. Hence it is elucidated that unexplained causes of 
cirrhosis do exist in some settings and can be treated 
adequately with better outcomes. Regardless of the 
cause, liver transplantation is the standard treatment for 
patients with chronic liver disease [32]. Consequently, 
the patient was advised for frequent follow-ups and liver 
transplantation.
CONCLUSION
Despite being a common disorder in the pediatric 
population, the etiology of chronic liver disease still 
remains a quandary in some settings as depicted by this 
case. This leads to a delay in appropriate management 
and eventual morbidity and mortality of children. In a 
resource-limited setting, making a diagnosis can be a 
challenge and all available resources need to be availed 
before drawing a conclusion.
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